Silencing of PYGB Suppresses Growth and Promotes the Apoptosis of Prostate Cancer Cells Via the NF‑κB/Nrf2 Signaling Pathway

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2018 Aug 15

PMID 30106110

Citations 21

Authors

Zhen Wang

Gang Han

Qinghong Liu

Wenyuan Zhang

Jinshan Wang

Affiliations

Soon will be listed here.

Abstract

Brain‑type glycogen phosphorylase (PYGB) is an enzyme that metabolizes glycogen, whose function is to provide energy for an organism in an emergency state. The present study purposed to investigate the role and mechanism of PYGB silencing on the growth and apoptosis of prostate cancer cells. A cell counting kit‑8 assay and flow cytometry were performed to determine the cell viability, apoptosis and reactive oxygen species (ROS) content, respectively. Colorimetry was performed to analyze the activity of caspase‑3. Western blotting and reverse transcription‑quantitative polymerase chain reaction were used to evaluate the associated mRNA and protein expression levels. The results revealed that PYGB was upregulated in prostate cancer tissues and was associated with disease progression. In addition, PYGB silencing suppressed the cell viability of PC3 cells. PYGB silencing promoted apoptosis of PC3 cells via the regulation of the expression levels of cleaved‑poly (adenosine diphosphate‑ribose) polymerase, cleaved‑caspase‑3, B‑cell lymphoma‑2 (Bcl‑2) and Bcl‑2‑associated X protein. PYGB silencing increased the ROS content in PC3 cells, and affected nuclear factor (NF)‑κB/nuclear factor‑erythroid 2‑related factor 2 (Nrf2) signaling pathways in PC3 cells. In conclusion, PYGB silencing suppressed the growth and promoted the apoptosis of prostate cancer cells by affecting the NF‑κB/Nrf2 signaling pathway. The present study provided evidence that may lead to the development of a potential therapeutic strategy for prostate cancer.

Citing Articles

Integrating Radiosensitivity Index and Radiation Resistance Related Index Improves Prostate Cancer Outcome Prediction.

Wu Q, Yin Z, Zhang Y, Lin Y, Jiang J, Zheng R Adv Radiat Oncol. 2025; 10(3):101713.

PMID: 40034476 PMC: 11872654. DOI: 10.1016/j.adro.2025.101713.

An 11-gene glycosyltransferases-related model for the prognosis of patients with bladder urothelial carcinoma: development and validation based on TCGA and GEO datasets.

Li W, Zuo K, Zhao Q, Guo C, Liu Z, Liu C Transl Androl Urol. 2025; 13(12):2771-2786.

PMID: 39816229 PMC: 11732298. DOI: 10.21037/tau-2024-632.

Luo D, Li X, Wei L, Yu Y, Hazaisihan Y, Tao L Sci Rep. 2024; 14(1):25239.

PMID: 39448713 PMC: 11502900. DOI: 10.1038/s41598-024-76945-2.

Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.

Yeyeodu S, Hanafi D, Webb K, Laurie N, Kimbro K Front Endocrinol (Lausanne). 2024; 14:1286979.

PMID: 38577257 PMC: 10991756. DOI: 10.3389/fendo.2023.1286979.

Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.

Ren L, Lu R, Fei X, Chen S, Liu P, Zhu C J Cancer Res Clin Oncol. 2024; 150(3):127.

PMID: 38483604 PMC: 10940407. DOI: 10.1007/s00432-024-05644-2.

References

Shaikh I, Brown I, Schofield A, Wahle K, Heys S . Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. Prostate. 2008; 68(15):1635-46. DOI: 10.1002/pros.20830. View

Surh Y . NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr. 2008; 17 Suppl 1:269-72. View

Lu L, Tang D, Wang L, Huang L, Jiang G, Xiao X . Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways. Acta Pharmacol Sin. 2012; 33(4):531-41. PMC: 4003358. DOI: 10.1038/aps.2011.180. View

Jayakumar S, Kunwar A, Sandur S, Pandey B, Chaubey R . Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity. Biochim Biophys Acta. 2013; 1840(1):485-94. DOI: 10.1016/j.bbagen.2013.10.006. View

Zhang C, Su Z, Khor T, Shu L, Kong A . Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem Pharmacol. 2013; 85(9):1398-404. PMC: 4123317. DOI: 10.1016/j.bcp.2013.02.010. View

Ma Q . Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53:401-26. PMC: 4680839. DOI: 10.1146/annurev-pharmtox-011112-140320. View

Sato K, MORRIS H, WEINHOUSE S . Phosphorylase: a new isozyme in rat hepatic tumors and fetal liver. Science. 1972; 178(4063):879-81. DOI: 10.1126/science.178.4063.879. View

Clarkson R, Watson C . NF-kappaB and apoptosis in mammary epithelial cells. J Mammary Gland Biol Neoplasia. 1999; 4(2):165-75. DOI: 10.1023/a:1018725207969. View

Kim S, Nishioka M, Hayashi S, Honda H, Kobayashi T, Taya M . The gene yggE functions in restoring physiological defects of Escherichia coli cultivated under oxidative stress conditions. Appl Environ Microbiol. 2005; 71(5):2762-5. PMC: 1087592. DOI: 10.1128/AEM.71.5.2762-2765.2005. View

10.

Rich S, Goodarzi M, Palmer N, Langefeld C, Ziegler J, Haffner S . A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS). Diabetologia. 2009; 52(7):1326-33. PMC: 2793118. DOI: 10.1007/s00125-009-1373-0. View

11.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

12.

Royle J, Ross J, Ansell I, Bollina P, Tulloch D, Habib F . Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. J Urol. 2004; 172(1):338-44. DOI: 10.1097/01.ju.0000132367.02834.41. View

13.

Newgard C, Hwang P, Fletterick R . The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol. 1989; 24(1):69-99. DOI: 10.3109/10409238909082552. View

14.

Shimada S, Maeno M, Akagi M, Hatayama I, Sato T, Sato K . Immunohistochemical detection of glycogen phosphorylase isoenzymes in rat and human tissues. Histochem J. 1986; 18(6):334-8. DOI: 10.1007/BF01675212. View

15.

Chen W, Zheng R, Zeng H, Zhang S, He J . Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015; 27(1):2-12. PMC: 4329176. DOI: 10.3978/j.issn.1000-9604.2015.01.06. View

16.

Baldwin Jr A . The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996; 14:649-83. DOI: 10.1146/annurev.immunol.14.1.649. View

17.

Mandal A, Bhatia D, Bishayee A . Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways. Nutrients. 2017; 9(5). PMC: 5452166. DOI: 10.3390/nu9050436. View

18.

Boyanapalli S, Paredes-Gonzalez X, Fuentes F, Zhang C, Guo Y, Pung D . Nrf2 knockout attenuates the anti-inflammatory effects of phenethyl isothiocyanate and curcumin. Chem Res Toxicol. 2014; 27(12):2036-43. PMC: 4269407. DOI: 10.1021/tx500234h. View

19.

Takashi M, Koshikawa T, Kurobe N, Kato K . Elevated concentrations of brain-type glycogen phosphorylase in renal cell carcinoma. Jpn J Cancer Res. 1989; 80(10):975-80. PMC: 5917874. DOI: 10.1111/j.1349-7006.1989.tb01636.x. View

20.

Ziady A, Sokolow A, Shank S, Corey D, Myers R, Plafker S . Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κB in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2012; 302(11):L1221-31. PMC: 3379036. DOI: 10.1152/ajplung.00156.2011. View